Healthy Skepticism Library references relevant to drug promotion: 2001

References relevant to drug promotion: 2001

This page lists all the 278 references relevant to drug promotion in the Healthy Skepticism library that were published in 2001 .

Click on the HSL (Health Skepticism Library) number for more details which may include an abstract or full text.

HSL2704
Sukkari S, Sasich L D.
Cisapride and patient information leaflets
Canadian Medical Association Journal 2001 May 01;164(9):1276-1278

HSL2606
Schwab D.
Patent protection is at forefront of the pharmaceutical industry's concerns for the coming years
STAR-LEDGER 2001 Dec 30

HSL2607
Kolata G.
Questions Grow Over Usefulness of Some Routine Cancer Tests
New York Times 2001 Dec 30

HSL2605
Freudenheim M, Petersen M.
The Drug-Price Express Runs Into a Wall
The New York Times 2001 Dec 23

HSL2603
Who Medicines Expert Calls For New Rules Against Commercial Bias In Medical Research
2001 Dec 17

HSL2604
Firn D.
Patent disputes and litigation take shine off 2001
Financial Times 2001 Dec 17

HSL2601
Protest against drug company manipulation of doctors' choice of drugs
2001 Dec 8

HSL2599
Japsen B.
Doctors ask to keep prescribing secret AMA data selling reaps $20 million
Chicago Tribune 2001 Dec 4

HSL2600
Steinman M.
New Study Shows Low-Income, Minority Seniors Restrict Use of Prescription Drugs
2001 Dec 4

HSL2597
Morse L.
Scenario: How a resident can spell relief from "ethical heartburn"
AMNews 2001 Dec 3

HSL2598
Greene J.
Medical groups tout AMA drug industry gift campaign
AMNews 2001 Dec 3

HSL4144
US FDA.
Direct-to-you: DTC ads that make sense. [Consumer Talk Paper]
Rockville, Md.: US FDA.; 2001 Dec 3
http://www.fda.gov/cder/about/whatwedo/testtube-11.pdf

HSL119
Wilkes MS, Hoffman JR.
An innovative approach to educating medical students about pharmaceutical promotion.
Acad Med 2001 Dec;76(12):1271-1277
http://www.academicmedicine.org/cgi/content/full/76/12/1271

HSL2608
Quick J.
Maintaining the integrity of the clinical evidence base
World Health Organisation Bulletin 2001 Dec

HSL2626
Weber LJ, Wayland MT, Holton B.
Health care professionals and industry: reducing conflicts of interest and established best practices.
Arch Phys Med Rehabil 2001 Dec;82(12)
http://linkinghub.elsevier.com/retrieve/pii/aapmr082b0s20

HSL2774
Newsweek 'adverzine'?
Consumers Union 2001 Dec:63

HSL2775
Anonymous .
DTC advertising: Mixed messages
CMJ 2001 Dec;133(10):20

HSL5921
Steinman MA, Sands LP, Covinsky KE.
Self-restriction of medications due to cost in seniors without prescription coverage.
J Gen Intern Med 2001 Dec;16(12):793-9
http://www.blackwell-synergy.com/doi/abs/10.1046/j.1525-1497.2001.10412.x

HSL8460
Lima HA.
Reimbursement issues for biotherapies: trends and future issues
ASHP Midyear Clinical Meeting 2001 Dec;36

HSL8461
Mangino MH, Ptachcinski RJ, Hrinya M, Stdenis J.
Five year experience with a medication acquisition cost reduction program for the indigent
ASHP Midyear Clinical Meeting 2001 Dec;36

HSL8462
Kostek NE.
Effective use of managed care contracting to improve inpatient revenues in an acute care setting
ASHP Midyear Clinical Meeting 2001 Dec;36

HSL8464
Haberman DJ, Clifton GD.
Development of an automated service to support access to pharmaceutical companies' patient assistance program
ASHP Midyear Clinical Meeting 2001 Dec;36

HSL8465
Shah ND.
Use of trend data on medication use volume in the forecasting process
ASHP Midyear Clinical Meeting 2001 Dec;36

HSL11122
Zanamivir: a second look - Still no tangible impact on influenza.
Prescrire Int 2001 Dec;10(56):175-7

HSL2596
Survey Finds DTC Ads Good for Communicating Basic Information
Reuters Health 2001 Nov 29

HSL2595
De Bourbon.
Poll: Many Don't Fill Prescriptions
AP Business Writer 2001 Nov 28

HSL2593
The Remicade Letters
CBS News 2001 Nov 27
http://www.cbc.ca/disclosure/archives/0111_letters/story.html

HSL2594
Marketing Medication
ABC News 2001 Nov 27

HSL2590
A complaint about drug company advertising
BMJ 2001 Nov 24

HSL2591
Selling drugs -- with a little help from a journalist
BMJ 2001 Nov 24

HSL2592
Sponsored journalism award shocks Australian media
BMJ 2001 Nov 24

HSL13652
Ashmore R, Carver N.
Mental health nursing. The pharmaceutical industry and mental health nursing.
British Journal of Nursing 2001 Nov 22;10(21):1396-402
http://www.britishjournalofnursing.com/

HSL2588
Silverman E.
Consumers buy what drug firms pitch
STAR-LEDGER 2001 Nov 21

HSL2587
Petersen M.
Increased Spending on Drugs Is Linked to More Advertising
New York Times 2001 Nov 21

HSL2585
Reporting of 6 Month vs 12 Month Data in a Clinical Trial of Celecoxib
JAMA 2001 Nov 21

HSL2589
Bristol-Myers Squibb Effort to Extend Glucophage Patent Galvanizes Congress and Divides Drug Industry
Kaisernetwork.org 2001 Nov 21

HSL2627
Wright JM, Perry TL, Bassett KL, Chambers GK.
Reporting of 6-month vs 12-month data in a clinical trial of celecoxib.
JAMA 2001 Nov 21;286(19):2398-400
Link to source with long URL

HSL2628
Hrachovec JB, Mora M.
Reporting of 6-month vs 12-month data in a clinical trial of celecoxib.
JAMA 2001 Nov 21;286(19):2398
http://jama.ama-assn.org/cgi/content/full/286/19/2398

HSL2629
Silverstein , Fred//simon , Lee//faich , Gerald .
Reporting of 6-month vs 12-month data in a clinical trial of celecoxib
JAMA 2001 Nov 21;286(19):2399-2400
http://jama.ama-assn.org/issues/v286n19/ffull/jlt1121-1.html

HSL2916
Wright JL, Perry TL, Bassett KL, Chambers GK.
Reporting of 6-month vs 12-month data in a clinical trial of celecoxib [2nd of 3 letters]
JAMA 2001 Nov 21;286(19):2398-9
http://jama.ama-assn.org/issues/v286n19/ffull/jlt1121-1.html

HSL2968
Hrachovec J, Mora M.
Reporting of 6-month vs 12-moth data in a clinical trial of celecoxib [1st of 3 letters]
JAMA 2001 Nov 21;286(19):2398
http://jama.ama-assn.org/issues/v286n19/ffull/jlt1121-1.html

HSL2586
Guerrera F, Jennen B.
Brussels to set record fines for vitamin cartel
Financial times 2001 Nov 20

HSL2583
Pinker S.
Medicine's intellectual property rights attacked in Osler lecture
eCMAJ 2001 Nov 19

HSL2584
Lieberman T.
Drug Discounts Offered to Foster Brand Loyalty
Los Angeles Times 2001 Nov 19

HSL2582
Mantz B.
Benefit Plan Accuses Bristol-Myers Of Fraud, Racketeering
Dow Jones Newswires 2001 Nov 19

HSL2581
Wolfe S.
The AMA Does It Again
2001 Nov 19

HSL2580
Seniors Go North For Cheaper Medication
Yahoo News 2001 Nov 16

HSL2578
Richwine L.
Pediatric Drug-Test Incentives Clear House
Reuters 2001 Nov 15

HSL2579
Davenport J.
Brand names carry price: Quebecers paid $18.7 million too much for drugs - generic manufacturers
Montreal Gazette 2001 Nov 15

HSL2577
McNeil D.
Tuberculosis Group Tries to Spur Research for New Antibiotics
New York Times 2001 Nov 15

HSL2576
Green Light to Put Public Health First at WTO Ministerial Conference in Doha
2001 Nov 14

HSL2575
Boseley S.
Tobacco giant buys rights to lung cancer drugs
The Age 2001 Nov 13

HSL2574
Agovino T.
Bristol-Myers Aims to Secure Monopoly
AP Business Writer 2001 Nov 12

HSL2573
Spurgeon D.
Report clears researcher who broke drug company agreement
BMJ 2001 Nov 10

HSL2572
Cassels A.
The new drug pushers
Montreal Gazette 2001 Nov 9

HSL2571
Lerner S.
The Bayer Boondoggle
Village Voice 2001 Nov 7

HSL242
Byron E.
The Web @ Work / Astra Zeneca: A Weekly Case Study
The Wall Street Journal 2001 Nov 5

HSL2570
Wayne L, Petersen M.
A Muscular Lobby Tries to Shape Nation's Bioterror Plan
New York Times 2001 Nov 4

HSL2920
Silverstein F, Simon L, Faich G.
Reporting of 6-month vs 12-month data in a clinical trial of celecoxib [3rd of 3 letters]
JAMA 2001 Nov 01;286(19):2399-2400
http://jama.ama-assn.org/issues/v286n19/ffull/jlt1121-1.html

HSL8449
Chisholm MA, Garrett CJ.
Increasing transplant patients' access to medications: Medicare and beyond.
Am J Health Syst Pharm 2001 Nov 1;58(21):2081-4
http://www.ajhp.org/cgi/reprint/58/21/2081

HSL2630
Meek C .
Direct-to-consumer advertising of prescription medicines: A review of international policy and evidence
Royal Pharmaceutical Society of Great Britain 2001 Nov
http://www.rpsgb.org.uk/pdfs/dtcarep.pdf

HSL2633
Brodie M.
Understanding the effects of direct-to-consumer prescription drug advertising
: Henry J. Kaiser Family Foundation; 2001 Nov

HSL2961
Meek C.
2001 Nov
http://www.rpsgb.org.uk/pdfs/dtcarep.pdf

HSL8445
Sullivan DL.
Evaluating information in consumer advertisements of prescription drugs.
Ann Pharmacother 2001 Nov;35(11):1494
http://www.theannals.com/cgi/reprint/35/11/1494-a

HSL2382
Sackett DL.
Why randomized controlled trials fail but needn't: 2 Failure to employ physiological statistics, or the only formula a clinician-trialist is ever likely to need (or understand!).
CMAJ 2001 Oct 30;165(9):1226-37
http://www.cmaj.ca/cgi/content/full/165/9/1226

HSL2510
McCormick BB, Tomlinson G, Brill-Edwards P, Detsky AS.
Effect of restricting contact between pharmaceutical company representatives and internal medicine residents on posttraining attitudes and behavior.
JAMA 2001 Oct 24-31;286(16):1994-9
http://jama.ama-assn.org/cgi/content/full/286/16/1994

HSL2565
Watson R.
Consumer groups fight plans for "direct to patient" drug advertisements
BMJ 2001 Oct 20

HSL5849
Attaran A, Gillespie-White L.
Do patents for antiretroviral drugs constrain access to AIDS treatment in Africa?
JAMA 2001 Oct 17;286(15):1886-92
http://jama.ama-assn.org/cgi/content/full/286/15/1886

HSL2564
Sanders's "Reasonable drug pricing" amendment
2001 Oct 15

HSL2562
Norton A.
Magazine Drug Ads Deemed Too Vague
Reuters Health 2001 Oct 5

HSL2563
News of Prescrire's Reps Monitoring Network:
Prescrire 2001 Oct 01

HSL2773
Telles Filho PC, Galdeano LE, Miasso AI, Caliri MH, Mendes IA.
[Drug administration and information dissemination via online]
Rev Bras Enferm 2001 Oct-Dec 01;54(4):539-47

HSL5314
Gupta AS.
Research on hire.
Issues Med Ethics 2001 Oct-Dec;9(4):111-3

HSL11123
News of Prescrire's reps monitoring network: pretences and off-label claims.
Prescrire Int 2001 Oct;10(55):146

HSL2166
Eliasson G, Hakansson J.
[Keep medical education independent! It should not be a scene of drug industry marketing]
Lakartidningen. 2001 Sep 26;98(39):4168-9

HSL5065
Elliott C.
Pharma buys a conscience.
Am Prospect 2001 Sep-Oct 24;12(17):16-20

HSL6118
FDA
NDA 21-042 Vioxx (rofecoxib) tablets MACMIS ID # 9456 WARNING LETTER
: FDA; 2001 Sep 21

HSL2560
Silversides A.
Ottawa assailed for reinterpreting ad law
The Globe and Mail 2001 Sep 18

HSL2561
Silversides A.
Looser ad rules a headache for drug plans
The Globe and Mail 2001 Sep 18

HSL7577
Davidoff F, DeAngelis CD, Drazen JM, Nicholls MG, Hoey J, Hojgaard L, Horton R, Kotzin S, Nylenna M, Overbeke AJ, Sox HC, Van Der Weyden MB, Wilkes MS; International Committee of Medical Journal Editors.
Sponsorship, authorship and accountability.
CMAJ 2001 Sep 18;165(6):786-8

HSL2525
Davidoff F, DeAngelis CD, Drazen JM, Hoey J, Hojgaard L, Horton R, Kotzin S, Nicholls MG, Nylenna M, Overbeke AJ, Sox HC, Van Der Weyden MB, Wilkes MS.
Sponsorship, authorship, and accountability.
Lancet 2001 Sep 15;358(9285):854-6
http://linkinghub.elsevier.com/retrieve/pii/S0140673601060354

HSL2558
Dyer O.
University accused of violating academic freedom to safeguard funding from drug companies
BMJ 2001 Sep 15

HSL14106
Eliasson M, Bergqvist D.
[Research results should be freely accessible!-- Case reports demonstrate obstacles to contact with drug industry].
Lakartidningen 2001 Sep 12;98(37):3913-6
http://www.ncbi.nlm.nih.gov/pubmed/11586830

HSL2637
McCarthy M.
Drug firm support of American Medical Association ethics effort draws fire.
Lancet 2001 Sep 8;358(9284):821
http://linkinghub.elsevier.com/retrieve/pii/S0140673601060214

HSL2557
Sigworth SK, Nettleman MD, Cohen GM.
Pharmaceutical Branding of Resident Physicians
JAMA 2001 09 05;286(9):1024-5

HSL8457
Sigworth SK, Nettleman MD, Cohen GM.
Pharmaceutical branding of resident physicians.
JAMA 2001 Sep 5;286(9):1024-5
http://jama.ama-assn.org/cgi/content/full/286/9/1024-a

HSL8033
Cooper RJ, Schriger DL, Wallace RC, Mikulich VJ, Wilkes MS
Graphics in Pharmaceutical Advertisements: Are They Truthful, Are They Adequately Detailed?
Los Angeles: UCLA School of Medicine; 2001 Sep
http://www.ama-assn.org/public/peer/prc_program2001.htm#truthful

HSL2720
Schwartz TL, Kuhles DJ 2nd, Wade M, Masand PS.
Newly admitted psychiatric patient prescriptions and pharmaceutical sales visits.
Ann Clin Psychiatry 2001 Sep;13(3):159-62
Link to source with long URL

HSL8398
Antonopoulos J.
Crossing the border: seniors turn to Canada and Mexico to fight high prescription costs
Acta Poloniae Pharmaceutica Drug Research 2001 Sep-Oct;4:4-7

HSL8442
Scheindlin S.
Acacia-remarkable excipient: past, present, and future of gum arabic
Journal of the American Pharmaceutical Association 2001 Sep-Oct;41:669-671

HSL2556
Okie S.
AMA Blasted for Letting Drug Firms Pay for Ethics Campaign
Washington Post 2001 Aug 30

HSL2553
The ASSOCIATED.
AMA Discourages Drug Co. Gifts
New York Times 2001 Aug 29

HSL2554
Guyatt G.
Don't allow drug firms to intimidate
Straightgoods 2001 Aug 29

HSL2555
Sheddan A.
Big tick for tighter DTC advertising rules
New Zealand Doctor 2001 Aug 29

HSL2552
Glaxo Is Sued Over Antidepressant
2001 Aug 26

HSL2638
Vallance P.
Releasing the grip of big pharma.
Lancet 2001 Aug 25;358(9282):664
http://linkinghub.elsevier.com/retrieve/pii/S0140673601057919

HSL2666
Reidenberg MM.
Releasing the grip of big pharma.
Lancet 2001 Aug 25;358(9282):664
http://linkinghub.elsevier.com/retrieve/pii/S0140673601057890

HSL2667
Conti Nibali S, Siracusano MF.
Releasing the grip of big pharma.
Lancet 2001 Aug 25;358(9282):664

HSL2917
Vallance P.
Releasing the grip of big pharma (3rd of 3 letters)
Lancet 2001 Aug 25;358:664

HSL2947
Reidenberg , M .
Releasing the grip of big pharma (1st of 3 letters)
Lancet 2001 Aug 25;358:664

HSL2953
Nibali S.
Releasing the grip of big pharma (2nd of 3 letters)
Lancet 2001 Aug 25;358:664

HSL2550
Burton T.
Study Raises Specter of Cardiac Risk
THE WALL STREET JOURNAL 2001 Aug 22

HSL2551
Gold R.
States Battling High Drug Costs
THE WALL STREET JOURNAL 2001 Aug 22

HSL2669
Silversides A.
Direct-to-consumer prescription drug ads getting bolder.
CMAJ 2001 Aug 21;165(4):462
http://www.cmaj.ca/cgi/content/full/165/4/462

HSL2549
Winslow R.
Pharmacy-Benefit Managers Launch
THE WALL STREET JOURNAL 2001 Aug 20

HSL129
Jones MI, Greenfield SM, Bradley CP.
Prescribing new drugs: qualitative study of influences on consultants and general practitioners
BMJ 2001;323:378-384
http://bmj.bmjjournals.com/cgi/content/full/323/7309/378

HSL2548
Pearl D.
Drug Firms' Incentives Fuel Abuse by Pharmacists in India
THE WALL STREET JOURNAL 2001 Aug 16

HSL2547
Picard A.
Policy critic likes Rock's prescription
Globe and Mail 2001 Aug 15

HSL2546
Milloy S.
Medical Journals Hooked on Drug Money
Fox News 2001 Aug 12

HSL2545
Kennedy M.
Rock may limit drugs covered by medicare
Ottawa Citizen 2001 Aug 11

HSL2544
States Seek New Methods To Lower Prescription Drug Costs
THE WALL STREET JOURNAL 2001 Aug 8

HSL2537
Greene J.
Rules governing drug firm CME sponsorship under review
amednews.com American Medical Association 2001 Aug 6

HSL2541
Blair J.
Healthy Skepticism and the Marketing of AIDS
New York Times 2001 Aug 5

HSL2542
Coulthart R.
The doctors' gravy train
Channel 9 TV Australia 2001 Aug 5

HSL2540
Adams C.
Glaxo Gets FDA Warning Letter On Improper Avandia Marketing
THE WALL STREET JOURNAL 2001 Aug 2

HSL2539
Nexium® Offers Unique Advantage Over Generic Omeprazole
www.qfever.com 2001 Aug 1

HSL2446
Beagan BL.
Even if I don't know what I'm doing I can make it look like I know what I'm doing: becoming a doctor in the 1990s.
Can Rev Sociol Anthropol 2001 Aug;38(3):275-92

HSL2672
Morgan , S .
An assessment of of the health system impact of direct-to-consumer advertising of prescription medicines (DTCA). Volume V: predicting the welfare and cost consequences of direct-to-consumer prescription advertising
Centre for Health Services and Policy Research 2001 Aug

HSL2674
Mintzes B Barber ML, Kazanjian K, Evans A
An assessment of the health system impact of direct-to-consumer advertising of prescription medicines (DTCA). Volume III: patient information on medicines. Comparative patient/doctor survey in Vancouver and Sacramento
Centre for Health Services & Policy Research 2001 Aug
http://www.chspr.ubc.ca//hpru/pdf/dtca-v3-compsurvey.pdf

HSL2955
Morgan S.
2001 Aug
www.chspr.ubc.ca//hpru/pdf/dtca-v5-econ.pdf

HSL2958
Mintzes , B BARER, Bassett K, Kazanjian A, Evans R.
Untitled
2001 Aug
www.chspr.ubc.ca//hpru/pdf/dtca-v3-compsurvey.pdf

HSL2960
Mintzes B.
2001 Aug
www.chspr.ubc.ca//hpru/pdf/dtca-v2-litreview.pdf

HSL8436
Wechsler J.
Medicare coverage Redux
Pharmaceutical Executive 2001 Aug;21:16, 18

HSL2675
Glass N.
European Commission may reform drug advertising legislation.
Lancet 2001 Jul 28;358(9278):306
http://linkinghub.elsevier.com/retrieve/pii/S0140673601055283

HSL8459
Court rules that Maine Rx can move forward
American Journal of Health System Pharmacy 2001 Jul 15;58:1286

HSL2533
Should there be systems in place to educate students and residents on appropriate interactions with pharmaceuticals? If so, what should they be?
AAMC Reporter 2001 Jul 10

HSL2535
Rx's and RSVP's: Pharmaceutical Companies Holding More Physician Meetings and Events
2001 Jul 9

HSL2538
Dippenaar J.
The Pharmaceutical Invasion
Meridian Healthcare 2001 Jul 9

HSL2534
Lowe R, Baumann B.
Does conflict of interest impact speaker credibility?
Canadian Associati0on of Emergency Physicians 2001 Jul 01;3(3)
http://www.caep.ca/page.asp?id=003261D25B654D3BA70F622628788B2C

HSL2695
Gonul F, Carter F, Petrova E, Srinivasan K.
Promotion of Prescription Drugs and its impact on Physicians’ Choice Behaviour
Journal of Marketing 2001 Jul;65:79-90
Nil

HSL5341
Thawani V.
Drug samples are meant for advertising.
Issues Med Ethics 2001 Jul-Sep;9(3):91

HSL8438
Vivian JC.
State prescription drug benefit plans
US Pharmacist 2001 Jul;26:46, 51-52, 55

HSL2532
Lenzer J.
The Benefit of the Bargain
Praxis Post 2001 Jun 27

HSL2677
Caro JJ, Payne K.
The value of industry-sponsored studies of initial antihypertensive therapies.
CMAJ 2001 Jun 26;164(13):1832-3
http://www.cmaj.ca/cgi/content/full/164/13/1832

HSL2678
Silversides , A .
Hospital denies that withdrawal of MD's job offer was related to drug-company funding
Canadian Medical Association Journal 2001 Jun 26;164(13):1879

HSL2772
Wright , J M.
The value of industry-sponsored studies of initial antihypertensive therapies
CMAJ 2001 Jun 26;164(13):1832-1833

HSL2915
Wright J.
The value of industry-sponsored studies of initial antihypertensive therapies (2nd of 2 letters)
Canadian Medical Association Journal 2001 Jun 26;164(13):1832-3

HSL2978
Caro JJ, Payne K.
The value of industry-sponsored studies of initial antihypertensive therapies (1st of 2 letters)
Canadian Medical Association Journal 2001 Jun 26;164(13):1832

HSL7578
Silversides A.
Hospital denies that withdrawal of MD's job offer was related to drug-company funding
Canadian Medical Association Journal 2001 Jun 16;164(13):1879

HSL2530
Silversides A.
Health Canada "reinterprets" laws about prescription drug ads for consumers
http://www.straightgoods.com/item456.asp 2001 Jun 11

HSL2529
Hilts P.
Jury Awards $6.4 Million In Killings Tied to Drug
2001 Jun 8

HSL2531
Demoro D.
The nursing shortage & the drug connection.
Revolution 2001 Jun

HSL2167
Marcoux H, Lamontagne C, Cayer S, Desrochers A, Gauthier D.
[The development of ethics. Identifying what training in medical ethics is needed by family physicians]
Can Fam Physician 2001 Jun;47:1208-15

HSL2957
Mintzes B, Kazanjian , Bassett K, Lexchin J.
Untitled
2001 Jun
www.chspr.ubc.ca//hpru/pdf/dtca-v4-expertsurvey.pdf

HSL2980
Bero L.
'Educational' advertisements - I haven't seen one yet!
Western Journal of Medicine 2001 Jun;174:395

HSL8520
Kinard ME.
Key components responsible for increasing drug costs
ASHP Annual Meeting 2001 Jun;58

HSL8521
Jackimiec JM.
Communicating utilization and critical issues to health providers
ASHP Annual Meeting 2001 Jun;58

HSL8523
Kostek NE.
Use of pharmacy carve-outs as a managed care strategy to recover pharmacy costs and generate revenues in an acute care setting
ASHP Annual Meeting 2001 Jun;58

HSL2523
Jackson T.
Are you being duped?
BMJ 2001 May 26;322:1312
http://bmj.bmjjournals.com/cgi/content/full/322/7297/1312

HSL2680
Ramsay S.
Online database reveals researchers' industry ties.
Lancet 2001 May 26;357(9269):1677
http://linkinghub.elsevier.com/retrieve/pii/S0140673600048625

HSL6147
Shann F.
Uses of error: the wrong research costs lives.
Lancet 2001 May 26;357(9269):1691
http://linkinghub.elsevier.com/retrieve/pii/S0140673600048790

HSL5851
Bailar JC 3rd.
The powerful placebo and the Wizard of Oz.
N Engl J Med 2001 May 24;344(21):1630-2
http://content.nejm.org/cgi/content/extract/344/21/1630

HSL2528
Chemist conflict demands scrutiny
The Australian Edition 2001 May 22

HSL2527
Bryden-brown S.
Drug giants underwrite chemists
The Weekend Australian 2001 May 19:3

HSL14004
Prescription drugs, Protection racket: Drug patent-holders under pressure
The Economist (US) 2001 May 19:4
http://www.economist.com/business/displaystory.cfm?story_id=E1_GNSQQG

HSL2682
Zitner D.
Prescription data
Canadian Medical Association Journal 2001 May 15;164(10):1408-1409

HSL2697
Short , S .
Prescription data
CMAG 2001 May 15;164(10):1408

HSL2698
Nucci , C .
One hundred pennies for your thoughts
Canadian Medical Association Journal 2001 May 15;164(10):1407

HSL2701
Korman , R .
Prescription data
CMAJ 2001 May 15;164(10):1408

HSL2702
Hammell , D .
One hundred pennies for your thoughts
CMAJ 2001 May 15;164(10):1408

HSL2703
One hundred pennies for your thoughts
CMAJ 2001 May 15;164(10):1409

HSL2770
The Editor.
One hundred pennies for your thoughts
CMAJ 2001 May 15;164(10):1407

HSL2913
Zoutman DE, Ford BD, Bassili AR.
Prescription data (5th of 5 letters)
Canadian Medical Association Journal 2001 May 15;164(10):1409-1410

HSL2946
Short S.
Prescription data (2nd of 5 letters)
Canadian Medical Association Journal 2001 May 15;164(10):1408

HSL2952
Nucci C.
One hundred pennies for your thoughts (1st of 2 letters)
Canadian Medical Association Journal 2001 May 15;164(10):1407

HSL2965
MacLeod S.
Prescription data (4th of 5 letters)
Canadian Medical Association Journal 2001 May 15;164(10):1409

HSL2967
Korman R.
Prescription data (1st of 5 letters)
Canadian Medical Association Journal 2001 May 15;164(10):1408

HSL2972
Hammell D.
One hundred pennies for your thoughts (2nd of 2 letters)
Canadian Medical Association Journal 2001 May 15;164(10):1407

HSL2977
Editor of CMAJ
One hundred pennies for your thoughts (response)
Canadian Medical Association Journal 2001 May 15;164(10):1407

HSL2705
Peterson , R G.
Cisapride and patient information leaflets
CMAJ 2001 May 1;164(10):1278

HSL2707
Muller , P .
Cisapride and patient information leaflets
CMAJ 2001 May 1;164(9):1278

HSL2708
Arnott , W .
Cisapride and patient information leaflets
CMAJ 2001 May 1;164(9):1278

HSL2914
Zitner D.
Prescription data (3rd of 5 letters)
Canadian Medical Association Journal 2001 May 01;164(10):1408-9

HSL2919
Sukkari S, Sasich , L .
Cisapride and patient information leaflets (1st of 4 letters)
Canadian Medical Association Journal 2001 May 1;164(9):1276-1278

HSL2949
Peterson R.
Cisapride and patient information leaflets (4th of 4 letters)
Canadian Medical Association Journal 2001 May 1;164(9):1278-9

HSL2954
Muller P.
Cisapride and patient information leaflets (3rd of 4 letters)
Canadian Medical Association Journal 2001 May 1;164(9):1278

HSL2981
Arnott W.
Cisapride and patient information leaflets (2nd of 4 letters)
Canadian Medical Association Journal 2001 May 1;164(9):1278

HSL8034
Gutknecht DR.
Evidence-based advertising?: A survey of four major journals.
J Am Board Fam Pract. 2001 May-Jun;14(3):197-200. 2001 May-Jun;14(3):197-200
http://www.jabfm.org/cgi/reprint/14/3/197

HSL2455
Kluger AN, Tikochinsky J.
The error of accepting the "theoretical" null hypothesis: the rise, fall, and resurrection of commonsense hypotheses in psychology.
Psychol Bull 2001 May;127(3):408-23
http://content.apa.org/journals/bul/127/3/408

HSL121
Stout E.
Doctoring sales
Sales & Marketing Management 2001 May:52-60
Nil

HSL2168
Steinman MA, Shlipak MG, McPhee SJ.
Of principles and pens: attitudes and practices of medicine housestaff toward pharmaceutical industry promotions.
Am J Med 2001 May;110(7):551-7
http://linkinghub.elsevier.com/retrieve/pii/S000293430100660X

HSL8433
Mudryj L, Richardson H.
Cyber prescriber
New Zealand Pharmacy 2001 May;21(33)

HSL8450
Gannon K.
Manufacturers share their thoughts about pharmacists
Hospital Pharmacist Report 2001 May;15:35-36

HSL2769
Høgh B, Clarke PD, Camus D, Chulay JD
Efficacy of atovaquone-proguanil?
The Lancet 2001 Apr 21;357:1289-1290

HSL2969
Hogh B, Clarke PD, Camus D, Chulay JD.
Efficacy of atovaquone-proguanil? (2nd of 2 letters)
The Lancet 2001 Apr 21;357:1289-1290

HSL2975
Croft A, Geary K, Morgan L.
Efficacy of atovaquone-proguanil? (1st of 2 letters)
The Lancet 2001 Apr 21;357:1289

HSL2170
Relman AS.
Separating continuing medical education from pharmaceutical marketing.
JAMA 2001 Apr 18;285(15):2009-12
http://jama.ama-assn.org/cgi/content/full/285/15/2009

HSL2369
McIlroy A.
Article censored that decried placebo use in drug trials
The Globe and Mail 2001 Apr 18

HSL8472
Relman AS.
Separating continuing medical education from pharmaceutical marketing.
JAMA 2001 Apr 18;285(15):2009-12
http://jama.ama-assn.org/cgi/content/full/285/15/2009

HSL8474
Holmer AF.
Industry strongly supports continuing medical education.
JAMA 2001 Apr 18;285(15):2012-4

HSL8470
Cassell D.
How manufacturers view pharmacists
Drug Topics 2001 Apr 16;145:47-48, 50, 52, 54

HSL2766
Kiln , M .
Industry-sponsored research
The Lancet 2001 Apr 14;357:1209-1210

HSL2973
The tightening grip of big pharma
Lancet 2001 Apr 14;357(9263):1141
http://linkinghub.elsevier.com/retrieve/pii/S0140673600043634

HSL3094
Anonymous .
Rebirth of a salesman
The Economist 2001 Apr 14

HSL2765
Kondro W.
Canadian university publishes new rules to protect scientists.
Lancet 2001 Apr 7;357(9262):1104
http://linkinghub.elsevier.com/retrieve/pii/S0140673600043221

HSL8475
Gebhart F.
Annual Rx survey: behind the numbers
Drug Topics 2001 Apr 2;145:48-50, 52, 55

HSL2169
Sluzki CE.
Drug-company influence on medical education in the U.S
Am J Orthopsychiatry. 2001 Apr;71(2):148-9
Link to source with long URL

HSL2171
Johnson RG.
Physician education and the pharmaceutical industry.
Chest 2001 Apr;119(4):995-6
http://www.chestjournal.org/cgi/content/full/119/4/995

HSL2763
Franklin , A .
Pharmaceutical companies and CME
OMR 2001 Apr;68(4):10

HSL2764
Goodman B.
Do drug company promotions influence physician behavior?
West J Med 2001 Apr;174(4):232-3

HSL8443
TI: Joint statement from CP and PGEU: Prescription-only medicines should not be advertised directly to the public
Farmaceutski Glasnik 2001 Apr;57:153-154

HSL2757
Lo B, Wolf L .
Conflict-of-interest policies
NEJM 2001 Mar 29;344(13):1018

HSL2758
McCrary , S. V, L B.Brody, B A.
Conflict-of-interest policies
NEJM 2001 Mar 29;344(13):1018

HSL2759
Miller FG.
To protect those who serve
NEJM 2001 Mar 29;344(13):1018-1019

HSL2760
Nurok , M .
Conflict-of-interest policies
NEJM 2001 Mar 29;344(13):1017

HSL2762
Topol , E J.
Conflict-of-interest policies
NEJM 2001 Mar 29;344(13):1017

HSL2918
Topol E.
Conflict-of-interest policies (1st of 6 letters)
New England Journal of Medicine 2001 Mar 29;344(13):1017

HSL2948
Ratain M.
Conflict-of-interest policies (3rd of 6 letters)
New England Journal of Medicine 2001 Mar 29;344(13):1018

HSL2951
Nurok M.
Conflict-of-interest policies (2nd of 6 letters)
New England Journal of Medicine 2001 Mar 29;344(13):1017

HSL2956
Miller F.
To protect those who serve (1st of 2 letters)
New England Journal of Medicine 2001 Mar 29;344(13):1018-9

HSL2963
McCrary SV, McCullough LB, Brody BA.
Conflict-of-interest policies (5th of 6 letters)
New England Journal of Medicine 2001 Mar 29;344(13):1018

HSL2964
Martin J, Kasper D.
Conflict-of-interest policies (6th of 6 letters)
New England Journal of Medicine 2001 Mar 29;344(13):1018

HSL2966
Lo B, Wolf L.
Conflict-of-interest policies (4th of 6 letters)
New England Journal of Medicine 2001 Mar 29;344(13):1018

HSL2974
Drazen J, Koski G.
To protect those who serve (2nd of 2 letters)
New England Journal of Medicine 2001 Mar 29;344(13):1019

HSL2380
Dieperink ME, Drogemuller L.
Industry-sponsored grand rounds and prescribing behavior.
JAMA 2001 Mar 21;285(11):1443-4
http://jama.ama-assn.org/cgi/content/full/285/11/1443

HSL2368
Byrne M.
Drug makers to operate in a new market
Australian Financial Review 2001 Mar 14

HSL10871
Willman D.
Risk Was Known as FDA OK'd Fatal Drug
Los Angeles Times 2001 Mar 11
http://www.lef.org/magazine/mag2001/june2001_report_fda.html

HSL5839
Marshall JN, Stewart M, Ostbye T.
Small-group CME using e-mail discussions. Can it work?
Can Fam Physician 2001 Mar 01;47:557-63

HSL2755
Belkin , L .
Prime time pushers
2001 Mar:31-37
http://motherjones.com/magazine/MA01/drug.html

HSL2950
Perkin R.
Why the PAAB is important
Annals RCPSC 2001 Mar;34(2):105

HSL8451
White K, Beall T.
Changing OTC landscape
Pharmaceutical Executive 2001 Mar;21:82, 84, 86, 88, 90

HSL8452
Bernacchi T.
Challenge of prescription drug pricing
Pharmaceutical Executive 2001 Mar;21:56-58, 60, 62, 64, 66, 68

HSL2367
Noonan D.
GM's War on Drug Costs.
Newsweek 2001 Feb 26:46

HSL2753
GM's war on drugs
Newsweek 2001 Feb 26:46-48

HSL2739
Buffett L , McCormick W
Unwanted freebies
CMAJ 2001 Feb 20;164(4):464

HSL2743
Gold , A .
A drug by any other name
CMAJ 2001 Feb 20;164(4):464

HSL2744
Hoey , J .
A drug by any other name
CMAJ 2001 Feb 20;164(4):464

HSL2970
Hoey J.
A drug by any other name (response)
Canadian Medical Association Journal 2001 Feb 20;164(4):464

HSL2366
Jackson L.
Paying the Price
Australian Brodcasting Corporation: 4 Corners 2001 Feb 19
http://www.abc.net.au/4corners/stories/4Cprograms_PAYINGTHE.htm

HSL2742
Weber W.
Sponsored continuing medical education under scrutiny in Europe
Lancet 2001 Feb 10;357:452

HSL9478
Gupta S.
Why le Carre’s ThreeBees will not sting India : Trust our immune system
Indian Express (Mumbai) 2001 Feb 10
http://www.expressindia.com/ie/daily/20010227/shekhar.htm

HSL2752
Sibbald , B .
Doctors asked to take pledge to shun drug company freebies
CMAJ 2001 Feb 01;164(4):531

HSL2741
Lal A.
Pharmaceutical drug promotion: how it is being practiced in India?
J Assoc Physicians India 2001 Feb;49:266-73

HSL2740
Therapeutic Products Programme.
Advertising Standards Canada and the Therapeutic Product Programme's roles and consultation related to advertising review and complaint adjudication
2001 Jan 22
Link to source with long URL

HSL8467
Van Diepen LR.
Pharmaceutical manufacturer assistance programs for indigent patients: solution or symptom?
Am J Health Syst Pharm 2001 Jan 15;58(2):162-3
http://www.ajhp.org/cgi/reprint/58/2/162

HSL8530
Mehl B, Santell J.
Projecting future drug expenditures--2001.
Am J Health Syst Pharm 2001 Jan 15;58(2):125-33
http://www.ajhp.org/cgi/reprint/58/2/125

HSL8531
Weiner S, Dischler J, Horvitz C.
Beyond pharmaceutical manufacturer assistance: broadening the scope of an indigent drug program.
Am J Health Syst Pharm 2001 Jan 15;58(2):146-50
http://www.ajhp.org/cgi/reprint/58/2/146

HSL8533
Kennedy A.
Additional Novartis products available through assistance programs
American Journal of Health System Pharmacy 2001 Jan 1;58:79

HSL5440
Jesani A.
Calls for advertising and market reforms in health care.
Issues Med Ethics 2001 Jan-Mar;9(1):19

HSL5441
Mamdani B, Mamdani M.
Ethics of professional advertising.
Issues Med Ethics 2001 Jan-Mar;9(1):18

HSL5442
Malpani A.
Doctors should be allowed to advertise.
Issues Med Ethics 2001 Jan-Mar;9(1):16-7

HSL5443
Pandya SK.
Advertising remains unethical even in the digital age.
Issues Med Ethics 2001 Jan-Mar;9(1):15

HSL8456
Cloutier M, Golenski J.
RxHealthValue offers three recommendations and cost research
Journal of Managed Care Pharmacy 2001 Jan-Feb;7:17-20

HSL8463
Ellen EF.
Visits From Pharmaceutical Reps
Psychiatric Times 2001 Jan;18(1)
http://www.psychiatrictimes.com/p010121.html

HSL2559
Sponsorship, authorship and accountability
CMAJ 2001

HSL118
Woloshin S, Schwartz LM, Tremmel J, Welch HG
Direct-to-consumer advertisements for prescription drugs: what are Americans being sold?
Lancet 2001;358:1141-1146
http://linkinghub.elsevier.com/retrieve/pii/S0140673601062547

HSL120
Vlassov V, Mansfield P, Lexchin J, Vlassova A.
Do drug advertisements in Russian medical journals provide essential information for safe prescribing?
West J Med 2001;174:391-394
Nil

HSL122
Sigworth SK, Nettleman MD, Cohen GM.
Pharmaceutical branding of resident physicians
JAMA 2001;JAMA:1024-1025
http://jama.ama-assn.org/cgi/content/full/286/9/1024-a

HSL123
Robinson J.
Prescription games: money, ego, and power inside the global pharmaceutical industry
Toronto: McClelland and Stewart; 2001
Link to source with long URL

HSL124
Montaner JSG, O'Shaughnessy MV, Schechter MT.
Industry-sponsored clinical research: a double-edged sword
Lancet 2001;385:1893-1895
Nil

HSL126
Lill DJ, Peterson RT.
Older adult portrayal in television commercials by pharmaceutical manufacturers: an analysis
Journal of Pharmaceutical Marketing & Management 2001;14(1):81-96
Nil

HSL127
Lewis S, Baird P, Evans RG, Ghali WA, Wright CJ, Gibson E, et al
Dancing with the porcupine: rules for governing the university-industry relationship
Can Med Assoc J 2001;165:783-785
http://www.cmaj.ca/cgi/content/full/165/6/783

HSL128
Kemmeren JM, Algra A, Grobbee DE.
Third generation oral contraceptives and risk of venous thrombosis: meta-analysis
BMJ 2001;323:131-134
http://bmj.bmjjournals.com/cgi/content/full/323/7305/131

HSL130
Gönül FF, Carter F, Petrova E, Srinivasan K.
Promotion of prescription drugs and its impact on physicians' choice behavior
Journal of Marketing 2001;65:79-90
Nil

HSL131
Findlay SD.
Direct-to-consumer promotion of prescription drugs: economic implications for patients, payers and providers
Pharmacoeconomics 2001;19(2):109-199
Nil

HSL2405
Ainslie G.
Breakdown of Will
Cambridge: Cambridge University Press; 2001
http://www.cambridge.org/uk/catalogue/catalogue.asp?isbn=0521596947

HSL2135
Okoro EO, Davies AE.
Sponsorship of educational programmes in Nigerian medical and pharmacy schools by pharmaceutical companies: possible risk implication for public health.
Ethics Med 2001 Spr;17(1):52-60

HSL2649
Sterne J, Smith G.
Sifting the evidence -- what's wrong with significance tests?
BMJ 2001;322:226-231
Link to source with long URL

HSL2735
Consumers' Association
Policy report: promotion of prescription drugs: public health or private profit?
Consumers' Association 2001

HSL2736
Eichner , R MAROONICK, T J.
A review of direct-to-consumer (DTC) advertising and sales of prescription drugs: does DTC advertising increase sales and market share?
Journal of Pharmaceutical Marketing & Management 2001;13(4):19-42

HSL2737
Mintzes B, Baraldi R .
Direct-to-consumer prescription drug advertising: when public health is no longer a priority
DES Action Canada 2001

HSL2738
Rubin , Ph .
Pharmaceutical advertising as a consumer empowerment device
Journal of Biolaw & Business 2001;4(4):59-65

HSL2959
Mintzes B, Baraldi R.
Direct to Consumer Prescription Drug Advertising: When preventing harm is no longer a priority
: DES Action Canada; 2001
http://www.web.net/~desact/anglais/anglais.html

HSL2962
Meek C.
2001
www.rpsgb.org.uk/pdfs/dtcarep.pdf

HSL2976
Consumers ASSOCIATION, .
dtca alliances organisations
2001

HSL2979
Canadian Medical Association
CMA Policy: Physicians and the pharmaceutical industry (Update 2001)
2001
Link to source with long URL

HSL5989
Rai AK.
The information revolution reaches pharmaceuticals: balancing innovation incentives, cost, and access in the post-genomics era.
Univ Ill Law Rev 2001;2001(1):173-210

HSL8396
Baqir W, Maguire A.
Doctors' and pharmacists' attitudes to the use of sugar-free and sugar-containing medicines in the elderly
International Journal of Pharmacy Practice 2001;9(3):177-184

HSL8399
DTC debate
Irish Pharmacy Journal 2001;79(137-138):140

HSL8432
E-commerce in pharmacy: opportunity or threat?
Acta-Farmaceutica-Bonaerense 2001;9(3):8-9, 16

HSL8435
Adachi T, Hara H, Hirano K.
Students' awareness about practical training in community prescription pharmacy
Japanese Journal of Pharmaceutical Health Care and Sciences 2001;27(4):386-391

HSL8437
Barlas S.
FDA proposed ruling on package inserts
P-and-T 2001;26:259

HSL8440
Do Dear Health Care Professional letters make a difference?
Hospital Pharmacy 2001;36:928

HSL8441
McPherson D.
Sweet taste of success: Tom Greene has a sure fire prescription for smiles
Community Pharmacist 2001;93(2):20-22

HSL8477
Framework for Research and Evaluation into the Effects of Managed Care on the Pharmaceutical Marketplace: excerpts from the final report
Journal of Research in Pharmaceutical Economics 2001;10(4):235-266

HSL8522
Frenia KJ, Maves MD, Toscani MR.
Rx to OTC switching...issues and answers
ASHP Annual Meeting 2001;58

HSL9476
Brynner R, Stephens T.
Dark Remedy: The Impact Of Thalidomide And Its Revival As A Vital Medicine
New York: Basic Books; 2001
http://www.perseusbooksgroup.com/basic/book_detail.jsp?isbn=0738205907

HSL2632
Perri M 3rd, Shinde S, Banavali R.
The past, present, and future of direct-to-consumer prescription drug advertising.
Clin Ther 2001 nov;21(10):1798-811
Link to source with long URL

		Healthy Skepticism Countering misleading drug promotion Home \| About us \| Site info \| Contact us \| Links \| Other What's new \| AdWatch \| HS Int News \| Library \| Fora
Home - www.healthyskepticism.org > library > 2001 : Updated 28 August, 2005
For you Free Updates Can we help you? Help the cause Join in Subscribe to Healthy Skepticism Updates Feedback If you like our work please tell others. If not, please tell us.		References relevant to drug promotion: 2001 This page lists all the 278 references relevant to drug promotion in the Healthy Skepticism library that were published in 2001 . Click on the HSL (Health Skepticism Library) number for more details which may include an abstract or full text. HSL2704 Sukkari S, Sasich L D. Cisapride and patient information leaflets Canadian Medical Association Journal 2001 May 01;164(9):1276-1278 HSL2606 Schwab D. Patent protection is at forefront of the pharmaceutical industry's concerns for the coming years STAR-LEDGER 2001 Dec 30 HSL2607 Kolata G. Questions Grow Over Usefulness of Some Routine Cancer Tests New York Times 2001 Dec 30 HSL2605 Freudenheim M, Petersen M. The Drug-Price Express Runs Into a Wall The New York Times 2001 Dec 23 HSL2603 Who Medicines Expert Calls For New Rules Against Commercial Bias In Medical Research 2001 Dec 17 HSL2604 Firn D. Patent disputes and litigation take shine off 2001 Financial Times 2001 Dec 17 HSL2601 Protest against drug company manipulation of doctors' choice of drugs 2001 Dec 8 HSL2599 Japsen B. Doctors ask to keep prescribing secret AMA data selling reaps $20 million Chicago Tribune 2001 Dec 4 HSL2600 Steinman M. New Study Shows Low-Income, Minority Seniors Restrict Use of Prescription Drugs 2001 Dec 4 HSL2597 Morse L. Scenario: How a resident can spell relief from "ethical heartburn" AMNews 2001 Dec 3 HSL2598 Greene J. Medical groups tout AMA drug industry gift campaign AMNews 2001 Dec 3 HSL4144 US FDA. Direct-to-you: DTC ads that make sense. [Consumer Talk Paper] Rockville, Md.: US FDA.; 2001 Dec 3 http://www.fda.gov/cder/about/whatwedo/testtube-11.pdf HSL119 Wilkes MS, Hoffman JR. An innovative approach to educating medical students about pharmaceutical promotion. Acad Med 2001 Dec;76(12):1271-1277 http://www.academicmedicine.org/cgi/content/full/76/12/1271 HSL2608 Quick J. Maintaining the integrity of the clinical evidence base World Health Organisation Bulletin 2001 Dec HSL2626 Weber LJ, Wayland MT, Holton B. Health care professionals and industry: reducing conflicts of interest and established best practices. Arch Phys Med Rehabil 2001 Dec;82(12) http://linkinghub.elsevier.com/retrieve/pii/aapmr082b0s20 HSL2774 Newsweek 'adverzine'? Consumers Union 2001 Dec:63 HSL2775 Anonymous . DTC advertising: Mixed messages CMJ 2001 Dec;133(10):20 HSL5921 Steinman MA, Sands LP, Covinsky KE. Self-restriction of medications due to cost in seniors without prescription coverage. J Gen Intern Med 2001 Dec;16(12):793-9 http://www.blackwell-synergy.com/doi/abs/10.1046/j.1525-1497.2001.10412.x HSL8460 Lima HA. Reimbursement issues for biotherapies: trends and future issues ASHP Midyear Clinical Meeting 2001 Dec;36 HSL8461 Mangino MH, Ptachcinski RJ, Hrinya M, Stdenis J. Five year experience with a medication acquisition cost reduction program for the indigent ASHP Midyear Clinical Meeting 2001 Dec;36 HSL8462 Kostek NE. Effective use of managed care contracting to improve inpatient revenues in an acute care setting ASHP Midyear Clinical Meeting 2001 Dec;36 HSL8464 Haberman DJ, Clifton GD. Development of an automated service to support access to pharmaceutical companies' patient assistance program ASHP Midyear Clinical Meeting 2001 Dec;36 HSL8465 Shah ND. Use of trend data on medication use volume in the forecasting process ASHP Midyear Clinical Meeting 2001 Dec;36 HSL11122 Zanamivir: a second look - Still no tangible impact on influenza. Prescrire Int 2001 Dec;10(56):175-7 HSL2596 Survey Finds DTC Ads Good for Communicating Basic Information Reuters Health 2001 Nov 29 HSL2595 De Bourbon. Poll: Many Don't Fill Prescriptions AP Business Writer 2001 Nov 28 HSL2593 The Remicade Letters CBS News 2001 Nov 27 http://www.cbc.ca/disclosure/archives/0111_letters/story.html HSL2594 Marketing Medication ABC News 2001 Nov 27 HSL2590 A complaint about drug company advertising BMJ 2001 Nov 24 HSL2591 Selling drugs -- with a little help from a journalist BMJ 2001 Nov 24 HSL2592 Sponsored journalism award shocks Australian media BMJ 2001 Nov 24 HSL13652 Ashmore R, Carver N. Mental health nursing. The pharmaceutical industry and mental health nursing. British Journal of Nursing 2001 Nov 22;10(21):1396-402 http://www.britishjournalofnursing.com/ HSL2588 Silverman E. Consumers buy what drug firms pitch STAR-LEDGER 2001 Nov 21 HSL2587 Petersen M. Increased Spending on Drugs Is Linked to More Advertising New York Times 2001 Nov 21 HSL2585 Reporting of 6 Month vs 12 Month Data in a Clinical Trial of Celecoxib JAMA 2001 Nov 21 HSL2589 Bristol-Myers Squibb Effort to Extend Glucophage Patent Galvanizes Congress and Divides Drug Industry Kaisernetwork.org 2001 Nov 21 HSL2627 Wright JM, Perry TL, Bassett KL, Chambers GK. Reporting of 6-month vs 12-month data in a clinical trial of celecoxib. JAMA 2001 Nov 21;286(19):2398-400 Link to source with long URL HSL2628 Hrachovec JB, Mora M. Reporting of 6-month vs 12-month data in a clinical trial of celecoxib. JAMA 2001 Nov 21;286(19):2398 http://jama.ama-assn.org/cgi/content/full/286/19/2398 HSL2629 Silverstein , Fred//simon , Lee//faich , Gerald . Reporting of 6-month vs 12-month data in a clinical trial of celecoxib JAMA 2001 Nov 21;286(19):2399-2400 http://jama.ama-assn.org/issues/v286n19/ffull/jlt1121-1.html HSL2916 Wright JL, Perry TL, Bassett KL, Chambers GK. Reporting of 6-month vs 12-month data in a clinical trial of celecoxib [2nd of 3 letters] JAMA 2001 Nov 21;286(19):2398-9 http://jama.ama-assn.org/issues/v286n19/ffull/jlt1121-1.html HSL2968 Hrachovec J, Mora M. Reporting of 6-month vs 12-moth data in a clinical trial of celecoxib [1st of 3 letters] JAMA 2001 Nov 21;286(19):2398 http://jama.ama-assn.org/issues/v286n19/ffull/jlt1121-1.html HSL2586 Guerrera F, Jennen B. Brussels to set record fines for vitamin cartel Financial times 2001 Nov 20 HSL2583 Pinker S. Medicine's intellectual property rights attacked in Osler lecture eCMAJ 2001 Nov 19 HSL2584 Lieberman T. Drug Discounts Offered to Foster Brand Loyalty Los Angeles Times 2001 Nov 19 HSL2582 Mantz B. Benefit Plan Accuses Bristol-Myers Of Fraud, Racketeering Dow Jones Newswires 2001 Nov 19 HSL2581 Wolfe S. The AMA Does It Again 2001 Nov 19 HSL2580 Seniors Go North For Cheaper Medication Yahoo News 2001 Nov 16 HSL2578 Richwine L. Pediatric Drug-Test Incentives Clear House Reuters 2001 Nov 15 HSL2579 Davenport J. Brand names carry price: Quebecers paid $18.7 million too much for drugs - generic manufacturers Montreal Gazette 2001 Nov 15 HSL2577 McNeil D. Tuberculosis Group Tries to Spur Research for New Antibiotics New York Times 2001 Nov 15 HSL2576 Green Light to Put Public Health First at WTO Ministerial Conference in Doha 2001 Nov 14 HSL2575 Boseley S. Tobacco giant buys rights to lung cancer drugs The Age 2001 Nov 13 HSL2574 Agovino T. Bristol-Myers Aims to Secure Monopoly AP Business Writer 2001 Nov 12 HSL2573 Spurgeon D. Report clears researcher who broke drug company agreement BMJ 2001 Nov 10 HSL2572 Cassels A. The new drug pushers Montreal Gazette 2001 Nov 9 HSL2571 Lerner S. The Bayer Boondoggle Village Voice 2001 Nov 7 HSL242 Byron E. The Web @ Work / Astra Zeneca: A Weekly Case Study The Wall Street Journal 2001 Nov 5 HSL2570 Wayne L, Petersen M. A Muscular Lobby Tries to Shape Nation's Bioterror Plan New York Times 2001 Nov 4 HSL2920 Silverstein F, Simon L, Faich G. Reporting of 6-month vs 12-month data in a clinical trial of celecoxib [3rd of 3 letters] JAMA 2001 Nov 01;286(19):2399-2400 http://jama.ama-assn.org/issues/v286n19/ffull/jlt1121-1.html HSL8449 Chisholm MA, Garrett CJ. Increasing transplant patients' access to medications: Medicare and beyond. Am J Health Syst Pharm 2001 Nov 1;58(21):2081-4 http://www.ajhp.org/cgi/reprint/58/21/2081 HSL2630 Meek C . Direct-to-consumer advertising of prescription medicines: A review of international policy and evidence Royal Pharmaceutical Society of Great Britain 2001 Nov http://www.rpsgb.org.uk/pdfs/dtcarep.pdf HSL2633 Brodie M. Understanding the effects of direct-to-consumer prescription drug advertising : Henry J. Kaiser Family Foundation; 2001 Nov HSL2961 Meek C. 2001 Nov http://www.rpsgb.org.uk/pdfs/dtcarep.pdf HSL8445 Sullivan DL. Evaluating information in consumer advertisements of prescription drugs. Ann Pharmacother 2001 Nov;35(11):1494 http://www.theannals.com/cgi/reprint/35/11/1494-a HSL2382 Sackett DL. Why randomized controlled trials fail but needn't: 2 Failure to employ physiological statistics, or the only formula a clinician-trialist is ever likely to need (or understand!). CMAJ 2001 Oct 30;165(9):1226-37 http://www.cmaj.ca/cgi/content/full/165/9/1226 HSL2510 McCormick BB, Tomlinson G, Brill-Edwards P, Detsky AS. Effect of restricting contact between pharmaceutical company representatives and internal medicine residents on posttraining attitudes and behavior. JAMA 2001 Oct 24-31;286(16):1994-9 http://jama.ama-assn.org/cgi/content/full/286/16/1994 HSL2565 Watson R. Consumer groups fight plans for "direct to patient" drug advertisements BMJ 2001 Oct 20 HSL5849 Attaran A, Gillespie-White L. Do patents for antiretroviral drugs constrain access to AIDS treatment in Africa? JAMA 2001 Oct 17;286(15):1886-92 http://jama.ama-assn.org/cgi/content/full/286/15/1886 HSL2564 Sanders's "Reasonable drug pricing" amendment 2001 Oct 15 HSL2562 Norton A. Magazine Drug Ads Deemed Too Vague Reuters Health 2001 Oct 5 HSL2563 News of Prescrire's Reps Monitoring Network: Prescrire 2001 Oct 01 HSL2773 Telles Filho PC, Galdeano LE, Miasso AI, Caliri MH, Mendes IA. [Drug administration and information dissemination via online] Rev Bras Enferm 2001 Oct-Dec 01;54(4):539-47 HSL5314 Gupta AS. Research on hire. Issues Med Ethics 2001 Oct-Dec;9(4):111-3 HSL11123 News of Prescrire's reps monitoring network: pretences and off-label claims. Prescrire Int 2001 Oct;10(55):146 HSL2166 Eliasson G, Hakansson J. [Keep medical education independent! It should not be a scene of drug industry marketing] Lakartidningen. 2001 Sep 26;98(39):4168-9 HSL5065 Elliott C. Pharma buys a conscience. Am Prospect 2001 Sep-Oct 24;12(17):16-20 HSL6118 FDA NDA 21-042 Vioxx (rofecoxib) tablets MACMIS ID # 9456 WARNING LETTER : FDA; 2001 Sep 21 HSL2560 Silversides A. Ottawa assailed for reinterpreting ad law The Globe and Mail 2001 Sep 18 HSL2561 Silversides A. Looser ad rules a headache for drug plans The Globe and Mail 2001 Sep 18 HSL7577 Davidoff F, DeAngelis CD, Drazen JM, Nicholls MG, Hoey J, Hojgaard L, Horton R, Kotzin S, Nylenna M, Overbeke AJ, Sox HC, Van Der Weyden MB, Wilkes MS; International Committee of Medical Journal Editors. Sponsorship, authorship and accountability. CMAJ 2001 Sep 18;165(6):786-8 HSL2525 Davidoff F, DeAngelis CD, Drazen JM, Hoey J, Hojgaard L, Horton R, Kotzin S, Nicholls MG, Nylenna M, Overbeke AJ, Sox HC, Van Der Weyden MB, Wilkes MS. Sponsorship, authorship, and accountability. Lancet 2001 Sep 15;358(9285):854-6 http://linkinghub.elsevier.com/retrieve/pii/S0140673601060354 HSL2558 Dyer O. University accused of violating academic freedom to safeguard funding from drug companies BMJ 2001 Sep 15 HSL14106 Eliasson M, Bergqvist D. [Research results should be freely accessible!-- Case reports demonstrate obstacles to contact with drug industry]. Lakartidningen 2001 Sep 12;98(37):3913-6 http://www.ncbi.nlm.nih.gov/pubmed/11586830 HSL2637 McCarthy M. Drug firm support of American Medical Association ethics effort draws fire. Lancet 2001 Sep 8;358(9284):821 http://linkinghub.elsevier.com/retrieve/pii/S0140673601060214 HSL2557 Sigworth SK, Nettleman MD, Cohen GM. Pharmaceutical Branding of Resident Physicians JAMA 2001 09 05;286(9):1024-5 HSL8457 Sigworth SK, Nettleman MD, Cohen GM. Pharmaceutical branding of resident physicians. JAMA 2001 Sep 5;286(9):1024-5 http://jama.ama-assn.org/cgi/content/full/286/9/1024-a HSL8033 Cooper RJ, Schriger DL, Wallace RC, Mikulich VJ, Wilkes MS Graphics in Pharmaceutical Advertisements: Are They Truthful, Are They Adequately Detailed? Los Angeles: UCLA School of Medicine; 2001 Sep http://www.ama-assn.org/public/peer/prc_program2001.htm#truthful HSL2720 Schwartz TL, Kuhles DJ 2nd, Wade M, Masand PS. Newly admitted psychiatric patient prescriptions and pharmaceutical sales visits. Ann Clin Psychiatry 2001 Sep;13(3):159-62 Link to source with long URL HSL8398 Antonopoulos J. Crossing the border: seniors turn to Canada and Mexico to fight high prescription costs Acta Poloniae Pharmaceutica Drug Research 2001 Sep-Oct;4:4-7 HSL8442 Scheindlin S. Acacia-remarkable excipient: past, present, and future of gum arabic Journal of the American Pharmaceutical Association 2001 Sep-Oct;41:669-671 HSL2556 Okie S. AMA Blasted for Letting Drug Firms Pay for Ethics Campaign Washington Post 2001 Aug 30 HSL2553 The ASSOCIATED. AMA Discourages Drug Co. Gifts New York Times 2001 Aug 29 HSL2554 Guyatt G. Don't allow drug firms to intimidate Straightgoods 2001 Aug 29 HSL2555 Sheddan A. Big tick for tighter DTC advertising rules New Zealand Doctor 2001 Aug 29 HSL2552 Glaxo Is Sued Over Antidepressant 2001 Aug 26 HSL2638 Vallance P. Releasing the grip of big pharma. Lancet 2001 Aug 25;358(9282):664 http://linkinghub.elsevier.com/retrieve/pii/S0140673601057919 HSL2666 Reidenberg MM. Releasing the grip of big pharma. Lancet 2001 Aug 25;358(9282):664 http://linkinghub.elsevier.com/retrieve/pii/S0140673601057890 HSL2667 Conti Nibali S, Siracusano MF. Releasing the grip of big pharma. Lancet 2001 Aug 25;358(9282):664 HSL2917 Vallance P. Releasing the grip of big pharma (3rd of 3 letters) Lancet 2001 Aug 25;358:664 HSL2947 Reidenberg , M . Releasing the grip of big pharma (1st of 3 letters) Lancet 2001 Aug 25;358:664 HSL2953 Nibali S. Releasing the grip of big pharma (2nd of 3 letters) Lancet 2001 Aug 25;358:664 HSL2550 Burton T. Study Raises Specter of Cardiac Risk THE WALL STREET JOURNAL 2001 Aug 22 HSL2551 Gold R. States Battling High Drug Costs THE WALL STREET JOURNAL 2001 Aug 22 HSL2669 Silversides A. Direct-to-consumer prescription drug ads getting bolder. CMAJ 2001 Aug 21;165(4):462 http://www.cmaj.ca/cgi/content/full/165/4/462 HSL2549 Winslow R. Pharmacy-Benefit Managers Launch THE WALL STREET JOURNAL 2001 Aug 20 HSL129 Jones MI, Greenfield SM, Bradley CP. Prescribing new drugs: qualitative study of influences on consultants and general practitioners BMJ 2001;323:378-384 http://bmj.bmjjournals.com/cgi/content/full/323/7309/378 HSL2548 Pearl D. Drug Firms' Incentives Fuel Abuse by Pharmacists in India THE WALL STREET JOURNAL 2001 Aug 16 HSL2547 Picard A. Policy critic likes Rock's prescription Globe and Mail 2001 Aug 15 HSL2546 Milloy S. Medical Journals Hooked on Drug Money Fox News 2001 Aug 12 HSL2545 Kennedy M. Rock may limit drugs covered by medicare Ottawa Citizen 2001 Aug 11 HSL2544 States Seek New Methods To Lower Prescription Drug Costs THE WALL STREET JOURNAL 2001 Aug 8 HSL2537 Greene J. Rules governing drug firm CME sponsorship under review amednews.com American Medical Association 2001 Aug 6 HSL2541 Blair J. Healthy Skepticism and the Marketing of AIDS New York Times 2001 Aug 5 HSL2542 Coulthart R. The doctors' gravy train Channel 9 TV Australia 2001 Aug 5 HSL2540 Adams C. Glaxo Gets FDA Warning Letter On Improper Avandia Marketing THE WALL STREET JOURNAL 2001 Aug 2 HSL2539 Nexium® Offers Unique Advantage Over Generic Omeprazole www.qfever.com 2001 Aug 1 HSL2446 Beagan BL. Even if I don't know what I'm doing I can make it look like I know what I'm doing: becoming a doctor in the 1990s. Can Rev Sociol Anthropol 2001 Aug;38(3):275-92 HSL2672 Morgan , S . An assessment of of the health system impact of direct-to-consumer advertising of prescription medicines (DTCA). Volume V: predicting the welfare and cost consequences of direct-to-consumer prescription advertising Centre for Health Services and Policy Research 2001 Aug HSL2674 Mintzes B Barber ML, Kazanjian K, Evans A An assessment of the health system impact of direct-to-consumer advertising of prescription medicines (DTCA). Volume III: patient information on medicines. Comparative patient/doctor survey in Vancouver and Sacramento Centre for Health Services & Policy Research 2001 Aug http://www.chspr.ubc.ca//hpru/pdf/dtca-v3-compsurvey.pdf HSL2955 Morgan S. 2001 Aug www.chspr.ubc.ca//hpru/pdf/dtca-v5-econ.pdf HSL2958 Mintzes , B BARER, Bassett K, Kazanjian A, Evans R. Untitled 2001 Aug www.chspr.ubc.ca//hpru/pdf/dtca-v3-compsurvey.pdf HSL2960 Mintzes B. 2001 Aug www.chspr.ubc.ca//hpru/pdf/dtca-v2-litreview.pdf HSL8436 Wechsler J. Medicare coverage Redux Pharmaceutical Executive 2001 Aug;21:16, 18 HSL2675 Glass N. European Commission may reform drug advertising legislation. Lancet 2001 Jul 28;358(9278):306 http://linkinghub.elsevier.com/retrieve/pii/S0140673601055283 HSL8459 Court rules that Maine Rx can move forward American Journal of Health System Pharmacy 2001 Jul 15;58:1286 HSL2533 Should there be systems in place to educate students and residents on appropriate interactions with pharmaceuticals? If so, what should they be? AAMC Reporter 2001 Jul 10 HSL2535 Rx's and RSVP's: Pharmaceutical Companies Holding More Physician Meetings and Events 2001 Jul 9 HSL2538 Dippenaar J. The Pharmaceutical Invasion Meridian Healthcare 2001 Jul 9 HSL2534 Lowe R, Baumann B. Does conflict of interest impact speaker credibility? Canadian Associati0on of Emergency Physicians 2001 Jul 01;3(3) http://www.caep.ca/page.asp?id=003261D25B654D3BA70F622628788B2C HSL2695 Gonul F, Carter F, Petrova E, Srinivasan K. Promotion of Prescription Drugs and its impact on Physicians’ Choice Behaviour Journal of Marketing 2001 Jul;65:79-90 Nil HSL5341 Thawani V. Drug samples are meant for advertising. Issues Med Ethics 2001 Jul-Sep;9(3):91 HSL8438 Vivian JC. State prescription drug benefit plans US Pharmacist 2001 Jul;26:46, 51-52, 55 HSL2532 Lenzer J. The Benefit of the Bargain Praxis Post 2001 Jun 27 HSL2677 Caro JJ, Payne K. The value of industry-sponsored studies of initial antihypertensive therapies. CMAJ 2001 Jun 26;164(13):1832-3 http://www.cmaj.ca/cgi/content/full/164/13/1832 HSL2678 Silversides , A . Hospital denies that withdrawal of MD's job offer was related to drug-company funding Canadian Medical Association Journal 2001 Jun 26;164(13):1879 HSL2772 Wright , J M. The value of industry-sponsored studies of initial antihypertensive therapies CMAJ 2001 Jun 26;164(13):1832-1833 HSL2915 Wright J. The value of industry-sponsored studies of initial antihypertensive therapies (2nd of 2 letters) Canadian Medical Association Journal 2001 Jun 26;164(13):1832-3 HSL2978 Caro JJ, Payne K. The value of industry-sponsored studies of initial antihypertensive therapies (1st of 2 letters) Canadian Medical Association Journal 2001 Jun 26;164(13):1832 HSL7578 Silversides A. Hospital denies that withdrawal of MD's job offer was related to drug-company funding Canadian Medical Association Journal 2001 Jun 16;164(13):1879 HSL2530 Silversides A. Health Canada "reinterprets" laws about prescription drug ads for consumers http://www.straightgoods.com/item456.asp 2001 Jun 11 HSL2529 Hilts P. Jury Awards $6.4 Million In Killings Tied to Drug 2001 Jun 8 HSL2531 Demoro D. The nursing shortage & the drug connection. Revolution 2001 Jun HSL2167 Marcoux H, Lamontagne C, Cayer S, Desrochers A, Gauthier D. [The development of ethics. Identifying what training in medical ethics is needed by family physicians] Can Fam Physician 2001 Jun;47:1208-15 HSL2957 Mintzes B, Kazanjian , Bassett K, Lexchin J. Untitled 2001 Jun www.chspr.ubc.ca//hpru/pdf/dtca-v4-expertsurvey.pdf HSL2980 Bero L. 'Educational' advertisements - I haven't seen one yet! Western Journal of Medicine 2001 Jun;174:395 HSL8520 Kinard ME. Key components responsible for increasing drug costs ASHP Annual Meeting 2001 Jun;58 HSL8521 Jackimiec JM. Communicating utilization and critical issues to health providers ASHP Annual Meeting 2001 Jun;58 HSL8523 Kostek NE. Use of pharmacy carve-outs as a managed care strategy to recover pharmacy costs and generate revenues in an acute care setting ASHP Annual Meeting 2001 Jun;58 HSL2523 Jackson T. Are you being duped? BMJ 2001 May 26;322:1312 http://bmj.bmjjournals.com/cgi/content/full/322/7297/1312 HSL2680 Ramsay S. Online database reveals researchers' industry ties. Lancet 2001 May 26;357(9269):1677 http://linkinghub.elsevier.com/retrieve/pii/S0140673600048625 HSL6147 Shann F. Uses of error: the wrong research costs lives. Lancet 2001 May 26;357(9269):1691 http://linkinghub.elsevier.com/retrieve/pii/S0140673600048790 HSL5851 Bailar JC 3rd. The powerful placebo and the Wizard of Oz. N Engl J Med 2001 May 24;344(21):1630-2 http://content.nejm.org/cgi/content/extract/344/21/1630 HSL2528 Chemist conflict demands scrutiny The Australian Edition 2001 May 22 HSL2527 Bryden-brown S. Drug giants underwrite chemists The Weekend Australian 2001 May 19:3 HSL14004 Prescription drugs, Protection racket: Drug patent-holders under pressure The Economist (US) 2001 May 19:4 http://www.economist.com/business/displaystory.cfm?story_id=E1_GNSQQG HSL2682 Zitner D. Prescription data Canadian Medical Association Journal 2001 May 15;164(10):1408-1409 HSL2697 Short , S . Prescription data CMAG 2001 May 15;164(10):1408 HSL2698 Nucci , C . One hundred pennies for your thoughts Canadian Medical Association Journal 2001 May 15;164(10):1407 HSL2701 Korman , R . Prescription data CMAJ 2001 May 15;164(10):1408 HSL2702 Hammell , D . One hundred pennies for your thoughts CMAJ 2001 May 15;164(10):1408 HSL2703 One hundred pennies for your thoughts CMAJ 2001 May 15;164(10):1409 HSL2770 The Editor. One hundred pennies for your thoughts CMAJ 2001 May 15;164(10):1407 HSL2913 Zoutman DE, Ford BD, Bassili AR. Prescription data (5th of 5 letters) Canadian Medical Association Journal 2001 May 15;164(10):1409-1410 HSL2946 Short S. Prescription data (2nd of 5 letters) Canadian Medical Association Journal 2001 May 15;164(10):1408 HSL2952 Nucci C. One hundred pennies for your thoughts (1st of 2 letters) Canadian Medical Association Journal 2001 May 15;164(10):1407 HSL2965 MacLeod S. Prescription data (4th of 5 letters) Canadian Medical Association Journal 2001 May 15;164(10):1409 HSL2967 Korman R. Prescription data (1st of 5 letters) Canadian Medical Association Journal 2001 May 15;164(10):1408 HSL2972 Hammell D. One hundred pennies for your thoughts (2nd of 2 letters) Canadian Medical Association Journal 2001 May 15;164(10):1407 HSL2977 Editor of CMAJ One hundred pennies for your thoughts (response) Canadian Medical Association Journal 2001 May 15;164(10):1407 HSL2705 Peterson , R G. Cisapride and patient information leaflets CMAJ 2001 May 1;164(10):1278 HSL2707 Muller , P . Cisapride and patient information leaflets CMAJ 2001 May 1;164(9):1278 HSL2708 Arnott , W . Cisapride and patient information leaflets CMAJ 2001 May 1;164(9):1278 HSL2914 Zitner D. Prescription data (3rd of 5 letters) Canadian Medical Association Journal 2001 May 01;164(10):1408-9 HSL2919 Sukkari S, Sasich , L . Cisapride and patient information leaflets (1st of 4 letters) Canadian Medical Association Journal 2001 May 1;164(9):1276-1278 HSL2949 Peterson R. Cisapride and patient information leaflets (4th of 4 letters) Canadian Medical Association Journal 2001 May 1;164(9):1278-9 HSL2954 Muller P. Cisapride and patient information leaflets (3rd of 4 letters) Canadian Medical Association Journal 2001 May 1;164(9):1278 HSL2981 Arnott W. Cisapride and patient information leaflets (2nd of 4 letters) Canadian Medical Association Journal 2001 May 1;164(9):1278 HSL8034 Gutknecht DR. Evidence-based advertising?: A survey of four major journals. J Am Board Fam Pract. 2001 May-Jun;14(3):197-200. 2001 May-Jun;14(3):197-200 http://www.jabfm.org/cgi/reprint/14/3/197 HSL2455 Kluger AN, Tikochinsky J. The error of accepting the "theoretical" null hypothesis: the rise, fall, and resurrection of commonsense hypotheses in psychology. Psychol Bull 2001 May;127(3):408-23 http://content.apa.org/journals/bul/127/3/408 HSL121 Stout E. Doctoring sales Sales & Marketing Management 2001 May:52-60 Nil HSL2168 Steinman MA, Shlipak MG, McPhee SJ. Of principles and pens: attitudes and practices of medicine housestaff toward pharmaceutical industry promotions. Am J Med 2001 May;110(7):551-7 http://linkinghub.elsevier.com/retrieve/pii/S000293430100660X HSL8433 Mudryj L, Richardson H. Cyber prescriber New Zealand Pharmacy 2001 May;21(33) HSL8450 Gannon K. Manufacturers share their thoughts about pharmacists Hospital Pharmacist Report 2001 May;15:35-36 HSL2769 Høgh B, Clarke PD, Camus D, Chulay JD Efficacy of atovaquone-proguanil? The Lancet 2001 Apr 21;357:1289-1290 HSL2969 Hogh B, Clarke PD, Camus D, Chulay JD. Efficacy of atovaquone-proguanil? (2nd of 2 letters) The Lancet 2001 Apr 21;357:1289-1290 HSL2975 Croft A, Geary K, Morgan L. Efficacy of atovaquone-proguanil? (1st of 2 letters) The Lancet 2001 Apr 21;357:1289 HSL2170 Relman AS. Separating continuing medical education from pharmaceutical marketing. JAMA 2001 Apr 18;285(15):2009-12 http://jama.ama-assn.org/cgi/content/full/285/15/2009 HSL2369 McIlroy A. Article censored that decried placebo use in drug trials The Globe and Mail 2001 Apr 18 HSL8472 Relman AS. Separating continuing medical education from pharmaceutical marketing. JAMA 2001 Apr 18;285(15):2009-12 http://jama.ama-assn.org/cgi/content/full/285/15/2009 HSL8474 Holmer AF. Industry strongly supports continuing medical education. JAMA 2001 Apr 18;285(15):2012-4 HSL8470 Cassell D. How manufacturers view pharmacists Drug Topics 2001 Apr 16;145:47-48, 50, 52, 54 HSL2766 Kiln , M . Industry-sponsored research The Lancet 2001 Apr 14;357:1209-1210 HSL2973 The tightening grip of big pharma Lancet 2001 Apr 14;357(9263):1141 http://linkinghub.elsevier.com/retrieve/pii/S0140673600043634 HSL3094 Anonymous . Rebirth of a salesman The Economist 2001 Apr 14 HSL2765 Kondro W. Canadian university publishes new rules to protect scientists. Lancet 2001 Apr 7;357(9262):1104 http://linkinghub.elsevier.com/retrieve/pii/S0140673600043221 HSL8475 Gebhart F. Annual Rx survey: behind the numbers Drug Topics 2001 Apr 2;145:48-50, 52, 55 HSL2169 Sluzki CE. Drug-company influence on medical education in the U.S Am J Orthopsychiatry. 2001 Apr;71(2):148-9 Link to source with long URL HSL2171 Johnson RG. Physician education and the pharmaceutical industry. Chest 2001 Apr;119(4):995-6 http://www.chestjournal.org/cgi/content/full/119/4/995 HSL2763 Franklin , A . Pharmaceutical companies and CME OMR 2001 Apr;68(4):10 HSL2764 Goodman B. Do drug company promotions influence physician behavior? West J Med 2001 Apr;174(4):232-3 HSL8443 TI: Joint statement from CP and PGEU: Prescription-only medicines should not be advertised directly to the public Farmaceutski Glasnik 2001 Apr;57:153-154 HSL2757 Lo B, Wolf L . Conflict-of-interest policies NEJM 2001 Mar 29;344(13):1018 HSL2758 McCrary , S. V, L B.Brody, B A. Conflict-of-interest policies NEJM 2001 Mar 29;344(13):1018 HSL2759 Miller FG. To protect those who serve NEJM 2001 Mar 29;344(13):1018-1019 HSL2760 Nurok , M . Conflict-of-interest policies NEJM 2001 Mar 29;344(13):1017 HSL2762 Topol , E J. Conflict-of-interest policies NEJM 2001 Mar 29;344(13):1017 HSL2918 Topol E. Conflict-of-interest policies (1st of 6 letters) New England Journal of Medicine 2001 Mar 29;344(13):1017 HSL2948 Ratain M. Conflict-of-interest policies (3rd of 6 letters) New England Journal of Medicine 2001 Mar 29;344(13):1018 HSL2951 Nurok M. Conflict-of-interest policies (2nd of 6 letters) New England Journal of Medicine 2001 Mar 29;344(13):1017 HSL2956 Miller F. To protect those who serve (1st of 2 letters) New England Journal of Medicine 2001 Mar 29;344(13):1018-9 HSL2963 McCrary SV, McCullough LB, Brody BA. Conflict-of-interest policies (5th of 6 letters) New England Journal of Medicine 2001 Mar 29;344(13):1018 HSL2964 Martin J, Kasper D. Conflict-of-interest policies (6th of 6 letters) New England Journal of Medicine 2001 Mar 29;344(13):1018 HSL2966 Lo B, Wolf L. Conflict-of-interest policies (4th of 6 letters) New England Journal of Medicine 2001 Mar 29;344(13):1018 HSL2974 Drazen J, Koski G. To protect those who serve (2nd of 2 letters) New England Journal of Medicine 2001 Mar 29;344(13):1019 HSL2380 Dieperink ME, Drogemuller L. Industry-sponsored grand rounds and prescribing behavior. JAMA 2001 Mar 21;285(11):1443-4 http://jama.ama-assn.org/cgi/content/full/285/11/1443 HSL2368 Byrne M. Drug makers to operate in a new market Australian Financial Review 2001 Mar 14 HSL10871 Willman D. Risk Was Known as FDA OK'd Fatal Drug Los Angeles Times 2001 Mar 11 http://www.lef.org/magazine/mag2001/june2001_report_fda.html HSL5839 Marshall JN, Stewart M, Ostbye T. Small-group CME using e-mail discussions. Can it work? Can Fam Physician 2001 Mar 01;47:557-63 HSL2755 Belkin , L . Prime time pushers 2001 Mar:31-37 http://motherjones.com/magazine/MA01/drug.html HSL2950 Perkin R. Why the PAAB is important Annals RCPSC 2001 Mar;34(2):105 HSL8451 White K, Beall T. Changing OTC landscape Pharmaceutical Executive 2001 Mar;21:82, 84, 86, 88, 90 HSL8452 Bernacchi T. Challenge of prescription drug pricing Pharmaceutical Executive 2001 Mar;21:56-58, 60, 62, 64, 66, 68 HSL2367 Noonan D. GM's War on Drug Costs. Newsweek 2001 Feb 26:46 HSL2753 GM's war on drugs Newsweek 2001 Feb 26:46-48 HSL2739 Buffett L , McCormick W Unwanted freebies CMAJ 2001 Feb 20;164(4):464 HSL2743 Gold , A . A drug by any other name CMAJ 2001 Feb 20;164(4):464 HSL2744 Hoey , J . A drug by any other name CMAJ 2001 Feb 20;164(4):464 HSL2970 Hoey J. A drug by any other name (response) Canadian Medical Association Journal 2001 Feb 20;164(4):464 HSL2366 Jackson L. Paying the Price Australian Brodcasting Corporation: 4 Corners 2001 Feb 19 http://www.abc.net.au/4corners/stories/4Cprograms_PAYINGTHE.htm HSL2742 Weber W. Sponsored continuing medical education under scrutiny in Europe Lancet 2001 Feb 10;357:452 HSL9478 Gupta S. Why le Carre’s ThreeBees will not sting India : Trust our immune system Indian Express (Mumbai) 2001 Feb 10 http://www.expressindia.com/ie/daily/20010227/shekhar.htm HSL2752 Sibbald , B . Doctors asked to take pledge to shun drug company freebies CMAJ 2001 Feb 01;164(4):531 HSL2741 Lal A. Pharmaceutical drug promotion: how it is being practiced in India? J Assoc Physicians India 2001 Feb;49:266-73 HSL2740 Therapeutic Products Programme. Advertising Standards Canada and the Therapeutic Product Programme's roles and consultation related to advertising review and complaint adjudication 2001 Jan 22 Link to source with long URL HSL8467 Van Diepen LR. Pharmaceutical manufacturer assistance programs for indigent patients: solution or symptom? Am J Health Syst Pharm 2001 Jan 15;58(2):162-3 http://www.ajhp.org/cgi/reprint/58/2/162 HSL8530 Mehl B, Santell J. Projecting future drug expenditures--2001. Am J Health Syst Pharm 2001 Jan 15;58(2):125-33 http://www.ajhp.org/cgi/reprint/58/2/125 HSL8531 Weiner S, Dischler J, Horvitz C. Beyond pharmaceutical manufacturer assistance: broadening the scope of an indigent drug program. Am J Health Syst Pharm 2001 Jan 15;58(2):146-50 http://www.ajhp.org/cgi/reprint/58/2/146 HSL8533 Kennedy A. Additional Novartis products available through assistance programs American Journal of Health System Pharmacy 2001 Jan 1;58:79 HSL5440 Jesani A. Calls for advertising and market reforms in health care. Issues Med Ethics 2001 Jan-Mar;9(1):19 HSL5441 Mamdani B, Mamdani M. Ethics of professional advertising. Issues Med Ethics 2001 Jan-Mar;9(1):18 HSL5442 Malpani A. Doctors should be allowed to advertise. Issues Med Ethics 2001 Jan-Mar;9(1):16-7 HSL5443 Pandya SK. Advertising remains unethical even in the digital age. Issues Med Ethics 2001 Jan-Mar;9(1):15 HSL8456 Cloutier M, Golenski J. RxHealthValue offers three recommendations and cost research Journal of Managed Care Pharmacy 2001 Jan-Feb;7:17-20 HSL8463 Ellen EF. Visits From Pharmaceutical Reps Psychiatric Times 2001 Jan;18(1) http://www.psychiatrictimes.com/p010121.html HSL2559 Sponsorship, authorship and accountability CMAJ 2001 HSL118 Woloshin S, Schwartz LM, Tremmel J, Welch HG Direct-to-consumer advertisements for prescription drugs: what are Americans being sold? Lancet 2001;358:1141-1146 http://linkinghub.elsevier.com/retrieve/pii/S0140673601062547 HSL120 Vlassov V, Mansfield P, Lexchin J, Vlassova A. Do drug advertisements in Russian medical journals provide essential information for safe prescribing? West J Med 2001;174:391-394 Nil HSL122 Sigworth SK, Nettleman MD, Cohen GM. Pharmaceutical branding of resident physicians JAMA 2001;JAMA:1024-1025 http://jama.ama-assn.org/cgi/content/full/286/9/1024-a HSL123 Robinson J. Prescription games: money, ego, and power inside the global pharmaceutical industry Toronto: McClelland and Stewart; 2001 Link to source with long URL HSL124 Montaner JSG, O'Shaughnessy MV, Schechter MT. Industry-sponsored clinical research: a double-edged sword Lancet 2001;385:1893-1895 Nil HSL126 Lill DJ, Peterson RT. Older adult portrayal in television commercials by pharmaceutical manufacturers: an analysis Journal of Pharmaceutical Marketing & Management 2001;14(1):81-96 Nil HSL127 Lewis S, Baird P, Evans RG, Ghali WA, Wright CJ, Gibson E, et al Dancing with the porcupine: rules for governing the university-industry relationship Can Med Assoc J 2001;165:783-785 http://www.cmaj.ca/cgi/content/full/165/6/783 HSL128 Kemmeren JM, Algra A, Grobbee DE. Third generation oral contraceptives and risk of venous thrombosis: meta-analysis BMJ 2001;323:131-134 http://bmj.bmjjournals.com/cgi/content/full/323/7305/131 HSL130 Gönül FF, Carter F, Petrova E, Srinivasan K. Promotion of prescription drugs and its impact on physicians' choice behavior Journal of Marketing 2001;65:79-90 Nil HSL131 Findlay SD. Direct-to-consumer promotion of prescription drugs: economic implications for patients, payers and providers Pharmacoeconomics 2001;19(2):109-199 Nil HSL2405 Ainslie G. Breakdown of Will Cambridge: Cambridge University Press; 2001 http://www.cambridge.org/uk/catalogue/catalogue.asp?isbn=0521596947 HSL2135 Okoro EO, Davies AE. Sponsorship of educational programmes in Nigerian medical and pharmacy schools by pharmaceutical companies: possible risk implication for public health. Ethics Med 2001 Spr;17(1):52-60 HSL2649 Sterne J, Smith G. Sifting the evidence -- what's wrong with significance tests? BMJ 2001;322:226-231 Link to source with long URL HSL2735 Consumers' Association Policy report: promotion of prescription drugs: public health or private profit? Consumers' Association 2001 HSL2736 Eichner , R MAROONICK, T J. A review of direct-to-consumer (DTC) advertising and sales of prescription drugs: does DTC advertising increase sales and market share? Journal of Pharmaceutical Marketing & Management 2001;13(4):19-42 HSL2737 Mintzes B, Baraldi R . Direct-to-consumer prescription drug advertising: when public health is no longer a priority DES Action Canada 2001 HSL2738 Rubin , Ph . Pharmaceutical advertising as a consumer empowerment device Journal of Biolaw & Business 2001;4(4):59-65 HSL2959 Mintzes B, Baraldi R. Direct to Consumer Prescription Drug Advertising: When preventing harm is no longer a priority : DES Action Canada; 2001 http://www.web.net/~desact/anglais/anglais.html HSL2962 Meek C. 2001 www.rpsgb.org.uk/pdfs/dtcarep.pdf HSL2976 Consumers ASSOCIATION, . dtca alliances organisations 2001 HSL2979 Canadian Medical Association CMA Policy: Physicians and the pharmaceutical industry (Update 2001) 2001 Link to source with long URL HSL5989 Rai AK. The information revolution reaches pharmaceuticals: balancing innovation incentives, cost, and access in the post-genomics era. Univ Ill Law Rev 2001;2001(1):173-210 HSL8396 Baqir W, Maguire A. Doctors' and pharmacists' attitudes to the use of sugar-free and sugar-containing medicines in the elderly International Journal of Pharmacy Practice 2001;9(3):177-184 HSL8399 DTC debate Irish Pharmacy Journal 2001;79(137-138):140 HSL8432 E-commerce in pharmacy: opportunity or threat? Acta-Farmaceutica-Bonaerense 2001;9(3):8-9, 16 HSL8435 Adachi T, Hara H, Hirano K. Students' awareness about practical training in community prescription pharmacy Japanese Journal of Pharmaceutical Health Care and Sciences 2001;27(4):386-391 HSL8437 Barlas S. FDA proposed ruling on package inserts P-and-T 2001;26:259 HSL8440 Do Dear Health Care Professional letters make a difference? Hospital Pharmacy 2001;36:928 HSL8441 McPherson D. Sweet taste of success: Tom Greene has a sure fire prescription for smiles Community Pharmacist 2001;93(2):20-22 HSL8477 Framework for Research and Evaluation into the Effects of Managed Care on the Pharmaceutical Marketplace: excerpts from the final report Journal of Research in Pharmaceutical Economics 2001;10(4):235-266 HSL8522 Frenia KJ, Maves MD, Toscani MR. Rx to OTC switching...issues and answers ASHP Annual Meeting 2001;58 HSL9476 Brynner R, Stephens T. Dark Remedy: The Impact Of Thalidomide And Its Revival As A Vital Medicine New York: Basic Books; 2001 http://www.perseusbooksgroup.com/basic/book_detail.jsp?isbn=0738205907 HSL2632 Perri M 3rd, Shinde S, Banavali R. The past, present, and future of direct-to-consumer prescription drug advertising. Clin Ther 2001 nov;21(10):1798-811 Link to source with long URL
1058 visits to this page since 1 January 2007		Home \| Add to Favourites \| Site Map \| Credits \| Privacy Policy \| Update Policy \| Feedback Policy

Countering misleading drug promotion

References relevant to drug promotion: 2001